Herpes Simplex Virus Type I Stromal Keratitis

Clinical trial pipeline · Data from ClinicalTrials.gov

See which Herpes Simplex Virus Type I Stromal Keratitis trials you may qualify for

Total trials

Actively recruiting

Phase 3 trials

Completed

Trial phase breakdown

Trial status

Actively recruiting — 1 trial

RecruitingPhase 2

NCT06474442

A Phase Ⅱa Study of the Safety, Tolerability and Efficacy of BD111 in Herpes Simplex Virus Type I Stromal Keratitis

This study aims to compare the clinical efficacy and safety of BD111 injection in combination with standard therapy vs. standard therapy in herpes simplex virus…

China40 participantsStarted 2025-04-28

Treatment: BD111 Injection (investigational new drug), Triple-drugs therapy of HSV-1 stromal keratitis

All recent trials (2 shown)

Active — Not RecruitingPhase 1

NCT06474416

A Study of the Safety, Tolerability and Prelinminary Efficacy of BD111 in Herpes Simplex Virus Type I Stromal Keratitis

This Phase I study is intended to evaluate the safety, tolerability, PK/PD profiles and preliminary efficacy via corneal intrastromal administration in patients…

China16 participantsStarted 2023-09-04

Treatment: BD111 Injection (Investigative New Drug), Triple-drugs therapy of HSV-1 stromal keratitis